0001209191-23-036733.txt : 20230613 0001209191-23-036733.hdr.sgml : 20230613 20230613163834 ACCESSION NUMBER: 0001209191-23-036733 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230609 FILED AS OF DATE: 20230613 DATE AS OF CHANGE: 20230613 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Randolph Sophia CENTRAL INDEX KEY: 0001817127 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39386 FILM NUMBER: 231011713 MAIL ADDRESS: STREET 1: C/O ALX ONCOLOGY HOLDINGS INC. STREET 2: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC CENTRAL INDEX KEY: 0001810182 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850642577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-466-7125 MAIL ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-09 0 0001810182 ALX ONCOLOGY HOLDINGS INC ALXO 0001817127 Randolph Sophia C/O ALX ONCOLOGY HOLDINGS INC. 323 ALLERTON AVENUE SOUTH SAN FRANCISO CA 94080 1 1 0 0 Chief Medical Officer 0 Common Stock 2023-06-09 4 M 0 4027 1.91 A 274280 D Common Stock 2023-06-09 4 M 0 2546 4.08 A 276826 D Common Stock 2023-06-09 4 M 0 6256 4.81 A 283082 D Employee Stock Option (right to buy) 1.91 2023-06-09 4 M 0 4027 0.00 D 2029-09-12 Common Stock 4027 0 D Employee Stock Option (right to buy) 4.08 2023-06-09 4 M 0 2546 0.00 D 2030-03-09 Common Stock 2546 92629 D Employee Stock Option (right to buy) 4.81 2023-06-09 4 M 0 6256 0.00 D 2030-04-27 Common Stock 6256 19084 D The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019. The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020. Shares subject to the option vest in 48 equal monthly installments beginning on May 27, 2020. /s/ Peter Garcia, by power of attorney 2023-06-13